Cost-Effectiveness of Early Treatment with First-Line NNRTI-Based HAART Regimens in the UK, 1996-2006-Reference-Cited by-同舟云学术

Cost-Effectiveness of Early Treatment with First-Line NNRTI-Based HAART Regimens in the UK, 1996-2006

Published:2011-05-25 Issue:5 Volume:6 Page:e20200
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Beck Eduard J.,Mandalia Sundhiya,Lo Gary,Sharott Peter,Youle Mike,Anderson Jane,Baily Guy,Brettle Ray,Fisher Martin,Gompels Mark,Kinghorn George,Johnson Margaret,McCarron Brendan,Pozniak Anton,Tang Alan,Walsh John,White David,Williams Ian,Gazzard Brian,

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference36 articles.

1. Rising Population Cost for Treating People Living with HIV in the UK, 1997–2013.;S Mandalia;PLoS ONE,2010

2. Treatment Outcome and Cost-effectiveness of different HAART Regimens in the UK 1996-2002.;EJ Beck;International Journal of STD & AIDS,2008

3. Interim Guidelines on Protecting the Confidentiality and Security of HIV information: Proceedings from a Workshop, 15–17 May 2006, Geneva, Switzerland.,2007

4. The Cost of HIV Treatment and Care in England since HAART: Part 1.;EJ Beck;British Journal of Sexual Medicine,2003

5. The Cost of HIV Treatment and Care in England since HAART: Part 2.;EJ Beck;British Journal of Sexual Medicine,2003

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-effectiveness of Cabotegravir Long-Acting for HIV Pre-exposure Prophylaxis in the United States;PharmacoEconomics;2024-01-24

2. BHIVA guidelines on antiretroviral treatment for adults living with HIV‐1 2022;HIV Medicine;2022-12

3. Hospital and community care costs for people newly diagnosed of living with HIV in London, UK;AIDS Care;2022-03-11

4. Is increased screening and early antiretroviral treatment for HIV ‐1 worth the investment? An analysis of the public health and economic impact of improvement in the UK;HIV Medicine;2019-08-08

5. British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015;HIV Medicine;2016-08